Seeking AlphaSat, 04 Jul 2026 07:48:41 GMTMirum Pharmaceuticals: This Liver Disease Juggernaut Just Broadened Its PortfolioMIRM-4.36%
Zacks Investment ResearchMon, 29 Jun 2026 15:56:13 GMTStrength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?MIRM-4.36%
Zacks Investment ResearchFri, 05 Jun 2026 16:35:54 GMTWhy Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?MIRM-4.36%
MarketBeatWed, 27 May 2026 11:09:41 GMTMirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline AdvanceMIRM-4.36%
Seeking AlphaTue, 12 May 2026 17:21:39 GMTMirum Pharmaceuticals: A Rare Disease Platform Becoming Bigger Than Its First FranchiseMIRM-4.36%
Zacks Investment ResearchThu, 07 May 2026 17:06:08 GMTMirum's Q1 Earnings & Revenues Beat Estimates, 2026 View RaisedMIRM-4.36%
Seeking AlphaThu, 07 May 2026 03:21:14 GMTMirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call TranscriptMIRM-4.36%
Zacks Investment ResearchWed, 06 May 2026 23:01:14 GMTHere's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 EarningsMIRM-4.36%
Zacks Investment ResearchWed, 06 May 2026 22:25:37 GMTMirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue EstimatesMIRM-4.36%
Seeking AlphaTue, 05 May 2026 00:43:41 GMTMirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta TranscriptMIRM-4.36%
BenzingaMon, 04 May 2026 15:15:10 GMTMirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease AssetsMIRM-4.36%
Zacks Investment ResearchFri, 17 Apr 2026 16:41:20 GMTWill Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?MIRM-4.36%
The Motley FoolMon, 13 Apr 2026 09:43:00 GMTPrediction: Buying This Biotech Stock Today Could Set You Up for LifeMIRM-4.36%